- Home
- ALZN vs LDWY Comparison
ALZN vs LDWY Comparison
Compare ALZN & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- LDWY
- Stock Information
- Founded
- ALZN 2016
- LDWY 1990
- Country
- ALZN United States
- LDWY United States
- Employees
- ALZN N/A
- LDWY N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- LDWY Advertising
- Sector
- ALZN Health Care
- LDWY Consumer Discretionary
- Exchange
- ALZN Nasdaq
- LDWY Nasdaq
- Market Cap
- ALZN 6.9M
- LDWY 6.7M
- IPO Year
- ALZN 2021
- LDWY 1991
- Fundamental
- Price
- ALZN $1.66
- LDWY $3.21
- Analyst Decision
- ALZN
- LDWY
- Analyst Count
- ALZN 0
- LDWY 0
- Target Price
- ALZN N/A
- LDWY N/A
- AVG Volume (30 Days)
- ALZN 271.9K
- LDWY 8.7K
- Earning Date
- ALZN 09-11-2024
- LDWY 11-11-2024
- Dividend Yield
- ALZN N/A
- LDWY N/A
- EPS Growth
- ALZN N/A
- LDWY N/A
- EPS
- ALZN N/A
- LDWY N/A
- Revenue
- ALZN N/A
- LDWY $24,813,000.00
- Revenue This Year
- ALZN N/A
- LDWY N/A
- Revenue Next Year
- ALZN N/A
- LDWY N/A
- P/E Ratio
- ALZN N/A
- LDWY N/A
- Revenue Growth
- ALZN N/A
- LDWY N/A
- 52 Week Low
- ALZN $1.40
- LDWY $3.12
- 52 Week High
- ALZN $34.50
- LDWY $6.88
- Technical
- Relative Strength Index (RSI)
- ALZN 39.08
- LDWY 35.20
- Support Level
- ALZN $1.55
- LDWY $3.32
- Resistance Level
- ALZN $1.68
- LDWY $3.62
- Average True Range (ATR)
- ALZN 0.14
- LDWY 0.19
- MACD
- ALZN 0.05
- LDWY -0.03
- Stochastic Oscillator
- ALZN 60.47
- LDWY 10.23
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.